Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates

A technology of prostaglandin and prostaglandin, which is applied in the field of prodrugs of positively charged water-soluble prostaglandins and related compounds with fast skin penetration speed, can solve problems such as destruction, pain, high cost and the like

Active Publication Date: 2009-09-16
TECHFIELDS BIOCHEM CO LTD
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Prostaglandins, when administered by injection, are painful and in many cases require frequent and expensive doctor visits to treat chronic disease states, and most prostaglandins, prostacyclins and related compounds do not reach their intended site of action Destroyed and inactivated in the blood and liver

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
  • Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
  • Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0064] N, the preparation method of N-diethylaminoethyl 11,15-diacetoxy-9-ketone-5,13-prostadienoic acid-1-amide acetate

[0065] 43.7 g (0.1 mol) of 11,15-diacetoxy-9-keto-5,13-prostadienoic acid were dissolved in 300 ml of chloroform. To the reaction mixture was added 20.6 g of N,N'-dicyclohexylcarboimide. To the reaction mixture was added 11.7 g of N,N-diethylaminoethylamine hydrogen bromide. The mixture was stirred at room temperature for 3 hours. The solids were removed by filtration. The chloroform solution was washed twice with 5% aqueous sodium bicarbonate, 100 ml each time, and washed three times with water, 100 ml each time. The organic layer was dried over anhydrous sodium sulfate. Sodium sulfate was removed by filtration. 6 g of acetic acid was added to the reaction mixture with stirring. 200ml of hexane was added. The solid product was collected by filtration. After drying, 45 g of the hygroscopic target product was obtained with a yield of 85.8%. Solubil...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The novel positively charged pro-drugs of prostaglandins, prostacyclins and related compounds in the general formula (2) 'Structure 2' were designed and synthesized. The compounds of the general formula (2) 'Structure 2' indicated above can be prepared from protected prostaglandins, prostacyclins, and related compounds, by reaction with suitable alcohols, thiols, or amines and coupling reagents, such as N, N'-Dicyclohexylcarbodiimide, N, N'-Diisopropylcarbodiimide, O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate, O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, Benzotriazol-1-yl-oxy-tris (dimethylamino)phosphonium hexafluorophosphate, et al. The positively charged amino groups of these pro-drugs not only largely increases the solubility of the drugs in water, but also bonds to the negative charge on the phosphate head group of membranes and pushes the pro-drug into the cytosol. The results suggest that the pro-drugs diffuse through human skin 1000 times faster than do prostaglandins, prostacyclins, and related compounds. In plasma, more than 90% of these pro-drugs can change back to the parent drugs in a few minutes. The prodrugs can be used medicinally in treating any prostaglandins, prostacyclins, and related compounds-treatable conditions in humans or animals. The prodrugs can be administered transdermally for any kind of medical treatments and avoid most of the side effects of prostaglandins, prostacyclins, and related compounds. Controlled transdermal administration systems of the prodrug enable prostaglandins, prostacyclins, and related compounds to reach constantly optimal therapeutic blood levels to increase effectiveness and reduce the side effects of prostaglandins, prostacyclins, and related compounds. Another great benefit of transdermal administration of these pro-drugs is that administering medication, especially to children, will be much easier.

Description

technical field [0001] The present invention relates to positively charged water-soluble prodrugs of prostaglandins, prostacyclins and related compounds and their use in the treatment of any prostaglandin, prostacyclin and related compounds treatable state in humans or animals. Specifically, the present invention is directed to the rapid penetration of the skin by prostaglandins, prostacyclins and related compounds. Background technique [0002] Natural prostaglandins and prostacyclins are eicosanoid-like compounds that are self-active substances derived from biomembrane phospholipids. They can be found almost anywhere on the body. The basic structure of prostaglandins is shown in structural formula 1. [0003] [0004] Structural Formula 1 [0005] All natural prostaglandins have a 15α-hydroxyl group and a C-13 trans double bond (William O. Foye, et al. Principles of Medicinal Chemistry, fourth edition, Williams & Wilkins, 1995, pg 538). Chains containing carboxyl gr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C215/40C07C215/42
CPCC07C405/0041A61P1/06A61P11/00A61P15/00A61P15/10A61P27/02A61P27/06A61P29/00A61P43/00A61P7/02A61P9/12
Inventor 于崇曦徐丽娜
Owner TECHFIELDS BIOCHEM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com